Frisch, A. (2026) “Cyclophosphamide for the Treatment of Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome Following CD19-Targeted CAR T-Cell Therapy”, Journal of Medical Cases, 17(1), pp. 28–31. doi:10.14740/jmc5211.